DrugPatentWatch Database Preview
Chartwell Molecules Company Profile
What is the competitive landscape for CHARTWELL MOLECULES, and what generic and branded alternatives to CHARTWELL MOLECULES drugs are available?
CHARTWELL MOLECULES has twenty approved drugs.
Summary for Chartwell Molecules
| US Patents: | 0 |
| Tradenames: | 15 |
| Ingredients: | 15 |
| NDAs: | 20 |
Drugs and US Patents for Chartwell Molecules
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Molecules | CLONIDINE HYDROCHLORIDE | clonidine hydrochloride | TABLET;ORAL | 071785-001 | Apr 5, 1988 | DISCN | No | No | Start Trial | Start Trial | |||||
| Chartwell Molecules | INDOMETHACIN | indomethacin | CAPSULE;ORAL | 070651-001 | Mar 5, 1986 | DISCN | No | No | Start Trial | Start Trial | |||||
| Chartwell Molecules | METRONIDAZOLE | metronidazole | TABLET;ORAL | 018930-001 | Aug 18, 1983 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
